Kiran J. Philip

发表

Review: The New Concept of ‘‘Interventional Heart Failure Therapy’’: Part 2—Inotropes, Valvular Disease, Pumps, and Transplantation

S. Simsir, E. Schwarz, Ernst R Schwarz, 2010, Journal of cardiovascular pharmacology and therapeutics.

Review Article: The New Concept of Interventional Heart Failure Therapy—Part 1: Electrical Therapy, Treatment of CAD, Fluid Removal, and Ventricular Support

Keith A. Thompson, A. Barbagelata, E. Schwarz, 2010, Journal of cardiovascular pharmacology and therapeutics.

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy

E. Schwarz, R. Morrissey, Kiran J. Philip, 2011, Cardiovascular journal of Africa.

Left ventricular noncompaction cardiomyopathy: updated review

E. Schwarz, A. Phan, R. Morrissey, 2013, Therapeutic advances in cardiovascular disease.

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension

E. Schwarz, Kiran J. Philip, Jeremy A Falk, 2010, Vascular health and risk management.

Review: Testosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure

E. Schwarz, Kiran J. Philip, R. Willix, 2011, Journal of cardiovascular pharmacology and therapeutics.

Growth hormone and testosterone in heart failure therapy

E. Schwarz, A. Phan, Kiran J. Philip, 2010, Expert opinion on pharmacotherapy.

Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure.

S. Hazen, A. Wu, F. van Lente, 2005, Clinical cornerstone.

Clinical Applications of Bivalirudin in the Cardiac Catheterization Laboratory

E. Schwarz, K. Thompson, Kiran J. Philip, 2011, Journal of cardiovascular pharmacology and therapeutics.

Gender Disparities in Health Resource Utilization in Patients with Atherosclerotic Cardiovascular Disease: A Retrospective Cross-Sectional Study

Kiran J. Philip, S. Dimario, Xian Shen, 2019, Advances in Therapy.

Case of fulminant giant-cell myocarditis associated with polymyositis, treated with a biventricular assist device and subsequent heart transplantation.

R. Kass, L. Czer, J. Rana, 2011, Heart & lung : the journal of critical care.

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

M. Brookhart, Kiran J. Philip, Leah J McGrath, 2020, Clinical Epidemiology.

CLEP_A_259757 835..845

Kiran J. Philip, Leah J McGrath, P. Dluzniewski, 2020 .

Plasma myeloperoxidase levels in patients with chronic heart failure.

S. Hazen, F. van Lente, M. Brennan, 2006, The American journal of cardiology.

The Effects of Spirituality and Religion on Outcomes in Patients with Chronic Heart Failure

E. Schwarz, A. Phan, Kiran J. Philip, 2012, Journal of Religion and Health.

Heart failure therapy: beyond the guidelines

E. Schwarz, K. Thompson, Kiran J. Philip, 2010, Journal of cardiovascular medicine.

Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system

T. N. Harrison, K. Reynolds, K. Monda, 2018, Vascular medicine.

Persistent sexual dysfunction impairs quality of life after cardiac transplantation.

W. Ishak, E. Schwarz, A. Phan, 2010, The journal of sexual medicine.

Adherence to Statin Therapy Among US Adults Between 2007 and 2014

M. Farkouh, K. Monda, P. Muntner, 2019, Journal of the American Heart Association.

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

R. Wade, Kiran J. Philip, S. Baum, 2021, American journal of preventive cardiology.

Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease

Deepak L. Bhatt, C. Cannon, C. Ballantyne, 2019, JAMA network open.

Persistent sexual dysfunction impairs quality of life after cardiac transplantation.

W. Ishak, E. Schwarz, A. Phan, 2010, The journal of sexual medicine.

Review: Testosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure

E. Schwarz, Kiran J. Philip, R. Willix, 2011, Journal of cardiovascular pharmacology and therapeutics.

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension

E. Schwarz, Kiran J. Philip, J. Falk, 2010, Vascular health and risk management.

Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system

T. N. Harrison, K. Reynolds, K. Monda, 2019, Vascular medicine.

TO IDENTIFY, EVALUATE, AND ANALYZE THE POSSIBLE DRUG-DRUG INTERACTIONS IN PATIENTS DIAGNOSED AS TYPE 2 DIABETES MELLITUS WITH HYPERTENSION IN A TERTIARY CARE TEACHING HOSPITAL

Kiran J. Philip, A. Joseph, S. Londhe, 2015 .